SUE BRUGMAN: Open Payments
NPI 1538501085 · SPENCER, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$171 in 4 payments from 4 companies in 2025. Trend: 2023 $131 · 2024 $173 · 2025 $171
Food & beverage: $171
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $61 |
| Amgen Inc. | 1 | $49 |
| Insulet Corporation | 1 | $45 |
| Lilly USA, LLC | 1 | $15 |
Products named: INGREZZA, KRYSTEXXA, OMNIPOD, MOUNJARO.
Industry payments across IA — which companies pay providers there.
